ENDRA Life Sciences Inc. 8-K

What Happened

• ENDRA Life Sciences, Inc. filed a Current Report on Form 8-K on March 31, 2026 (Item 2.02) announcing its financial results for the quarter and full year ended December 31, 2025. The company issued a press release reporting those results.

Key Details

• Form 8-K filed March 31, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• The company’s press release announcing the quarter and year‑end results is furnished as Exhibit 99.1 to the 8-K.
• The filing also includes the Cover Page Interactive Data File (Inline XBRL) as Exhibit 104.

Why It Matters

• This filing provides investors the company’s latest earnings and financial condition for Q4 and full-year 2025—key information for evaluating recent performance and near-term prospects.
• Investors should read the furnished press release (Exhibit 99.1) for details on revenue, net income/loss, cash position, and any management commentary that could affect valuation or future plans.